HANDS Act

The HANDS Act would amend Medicare, Medicaid, and TRICARE to provide no-cost coverage for preventive opioid overdose reversal drugs (such as naloxone) distributed by hospitals, critical access hospitals, rural emergency hospitals, emergency departments, or ambulatory surgical centers to individuals determined to be at risk for opioid overdose at the time of discharge or departure, effective January 1, 2026. It prohibits cost sharing, including deductibles and copayments, for these drugs under Medicare, Medicaid, and TRICARE, and requires federal agencies to issue guidance to state boards and hospitals on safe distribution and billing practices within one year of enactment. The bill does not…

No official summary is available here. This one was written by AI from the bill’s text.